» Download Public Reports
30 reports
- Company report
- June 2012
- 2 pages
... eye care * as of june 27, 2012, we have changed our organizational structure to three in-house companies. As a result, the former eye care business unit became the eye care company. The vision ...
March 2012
... A to allocate the company resources to two divisions of Positioning business And eye care business . As the result, we could expect the cost reduction by 10 billion yen Reduction of fixed ...
March 2012
... cardiology products (ivp) and critical care products (ccp). The ivp business is driven by the sales of its des products using technology developed in house. The company also collects royalty and licensing ...
December 2011
... Gross margins combined with controlled cost structure in place lidco gaining a differentiated presence in the hospital surgery and critical care space progress during the period 3 4 financial progress 5 operational ...
May 2011
... Excluding the u.S. dermatology business. Takeda is committed to transforming our organization through the acquisition of nycomed. Nycomed enables takeda to maximize the value of our portfolio and gives ...
March 2011
... Are Cardiovascular & metabolic, Oncology, Central nervous system, Respiratory & immunology, And general medicine (gastrointestinal and genitourinary). Takeda will strengthen its foundational drug discovery ...
March 2011
... Track record in safety and efficacy of interventional cardiology products such as des. Hence, we believe that big offers a huge competitive advantage on this aspect. Moreover, as the absorb Bvs ...
March 2011
... Net sales in internal medicines business ( Millions ...
March 2011
... Helps to underpin and solidify our business. In our domestic market, the size of the fluid and hemodynamic monitoring market continues to increase strongly. Our intensive care and surgical ...